Adovate

Adovate is a pharmaceutical company developing novel drugs targeting adenosine receptors, which are involved in major diseases. These best-in-class drug candidates have been created using our adenosine drug development platform, which has enabled us to design patentable compounds with favorable physiochemical characteristics (e.g., potency, selectivity, biodistribution) to overcome issues that historically limited the targeting of adenosine receptors. This platform is the cornerstone of our company and confers a competitive advantage that will allow us to broaden our future drug pipeline efficiently and economically.